Common Contracts
3 similar Loan and Security Agreement contracts by Accentia Biopharmaceuticals Inc, Biovest International Inc
Loan and Security Agreement (Loan to AutovaxID Investment LLC, for Investment Through St. Louis New Markets Tax Credit Fund-II, LLC into a portion of Biovest International Inc.’s subsidiary, AutovaxID, Inc., qualifying as a QALICB under Section 45D of...Loan and Security Agreement • December 14th, 2006 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS LOAN AND SECURITY AGREEMENT (this “Agreement”), made as of December 8, 2006 (the “Effective Date”), by AutovaxID Investment LLC, a Missouri limited liability company (“Borrower”), having an office at 1015 Locust Street, Suite 1200, St. Louis, Missouri 63101, for the benefit of Biolender II, LLC, a Delaware limited liability company, its successors and/or assigns (“Lender”), having an office at 324 S. Hyde Park Ave., Suite 350, Tampa, Florida 33606.
Loan and Security Agreement (Loan to Biovax Investment LLC, for Investment Through Telesis CDE Two, LLC into a portion of Biovest International Inc.’s subsidiary, Biovax, Inc., qualifying as a QALICB under Section 45D of the Internal Revenue Code)Loan and Security Agreement • May 2nd, 2006 • Biovest International Inc • Pharmaceutical preparations • Delaware
THIS LOAN AND SECURITY AGREEMENT (this “Agreement”), made as of April 25, 2006 (the “Effective Date”), by Biovax Investment LLC, a Delaware limited liability company (“Borrower”), having an office at 1101 30th Street, NW, Fourth Floor, Washington, DC 20007, for the benefit of Biolender, LLC, a Delaware limited liability company, its successors and/or assigns (“Lender”), having an office at 324 S. Hyde Park Ave., Suite 350, Tampa, Florida 33606.
Loan and Security Agreement (Loan to Biovax Investment LLC, for Investment Through Telesis CDE Two, LLC into a portion of Biovest International Inc.’s subsidiary, Biovax, Inc., qualifying as a QALICB under Section 45D of the Internal Revenue Code)Loan and Security Agreement • May 2nd, 2006 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS LOAN AND SECURITY AGREEMENT (this “Agreement”), made as of April 25, 2006 (the “Effective Date”), by Biovax Investment LLC, a Delaware limited liability company (“Borrower”), having an office at 1101 30th Street, NW, Fourth Floor, Washington, DC 20007, for the benefit of Biolender, LLC, a Delaware limited liability company, its successors and/or assigns (“Lender”), having an office at 324 S. Hyde Park Ave., Suite 350, Tampa, Florida 33606.
